ViGeneron Rebrands as VeonGen Therapeutics, Accelerates Clinical Pipeline in IRDs
VeonGen Therapeutics debuts with FDA recognition and bold plans for inherited eye diseases. ViGeneron (Munich, Germany) announced its rebranding as…
VeonGen Therapeutics debuts with FDA recognition and bold plans for inherited eye diseases. ViGeneron (Munich, Germany) announced its rebranding as…